Pulse Biosciences, Inc. Increase (Decrease) in Other Operating Liabilities
Pulse Biosciences, Inc. (PLSE) reported Increase (Decrease) in Other Operating Liabilities of $2.24 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2021-03-12
- Pulse Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-09-30 was -$41.00K.
- Pulse Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-06-30 was $2.27M.
- Pulse Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-03-31 was $6.00K.
- Pulse Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2018-12-31 was -$101.00K.
- Pulse Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2018 was -$397.00K.
- Pulse Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2017 was -$109.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $2.23M derived: sum of 2 quarters · filed 2020-11-09 | $2.24M 10-Q · filed 2020-11-09 | $2.14M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.28M 10-Q · filed 2020-08-10 | $2.18M derived: sum of 3 quarters · filed 2021-03-12 | $2.08M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $6.00K 10-Q · filed 2020-05-11 | -$95.00K derived: sum of 2 quarters · filed 2021-03-12 | -$197.00K derived: sum of 3 quarters · filed 2021-03-12 | -$294.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$203.00K derived: sum of 2 quarters · filed 2021-03-12 | -$300.00K derived: sum of 3 quarters · filed 2021-03-12 | -$397.00K 10-K · filed 2021-03-12 |
| 2018-09-30 | -$102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$199.00K derived: sum of 2 quarters · filed 2019-11-07 | -$296.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$194.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$97.00K 10-Q · filed 2019-05-03 | |||
| 2017-12-31 | -$109.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |